Science

Pashtoon Kasi: ASCO GI25 – More about the immunotherapy BOT/BAL

Pashtoon Kasi/LinkedIn

Dec 19, 2024, 15:19

Pashtoon Kasi: ASCO GI25 – More about the immunotherapy BOT/BAL

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, Orange County, shared a post on LinkedIn:

“ASCO GI25 More about the immunotherapy BOT/BAL.

Neoadjuvant:

NEST – BOT/BAL
UNICORN – BOT+/-BAL

Metastatic: Marwan Fakih at City of Hope

BOT+/-BAL

Plus Combinations

FOLFOX-3B (BEV+BOT+BAL)
iNKT+RAM+TAX+ BOT+BAL

Colorectal Cancer Alliance 2024 Advancements.”

Pashtoon Kasi: ASCO GI25 - More about the immunotherapy BOT/BAL

More posts featuring Pashtoon Kasi.

Dr. Pashtoon Kasi is the Medical Director of GI Medical Oncology at City of Hope, Orange County. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic.

He also served as the Director of Colon Cancer Research and Director of Precision Medicine Research for Liquid Biopsies at Weill Cornell Medicine.

His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.”

His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals. He also received the Yvonne Award 2024 by OncoDaily in the “challenging the status quo” category.